Advanced Biomedical Technologies (OTCMKTS:ABMT) vs. Sintx Technologies (NASDAQ:SINT) Head-To-Head Survey

Sintx Technologies (NASDAQ:SINT) and Advanced Biomedical Technologies (OTCMKTS:ABMT) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings and profitability.

Profitability

This table compares Sintx Technologies and Advanced Biomedical Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sintx Technologies	-1,058.60%	-366.49%	-115.04%
Advanced Biomedical Technologies	N/A	N/A	N/A

Insider & Institutional Ownership

18.4% of Sintx Technologies shares are owned by institutional investors. 4.1% of Sintx Technologies shares are owned by company insiders. Comparatively, 34.1% of Advanced Biomedical Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Valuation and Earnings

This table compares Sintx Technologies and Advanced Biomedical Technologies”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sintx Technologies	$1.02 million	6.61	-$10.36 million	($5.07)	-0.31
Advanced Biomedical Technologies	N/A	N/A	N/A	N/A	N/A

Advanced Biomedical Technologies has lower revenue, but higher earnings than Sintx Technologies.

Risk and Volatility

Sintx Technologies has a beta of 0.63, indicating that its stock price is 37% less volatile than the S&P 500. Comparatively, Advanced Biomedical Technologies has a beta of 1.48, indicating that its stock price is 48% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent recommendations for Sintx Technologies and Advanced Biomedical Technologies, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sintx Technologies	1	0	3	0	2.50
Advanced Biomedical Technologies	0	0	0	0	0.00

Sintx Technologies currently has a consensus price target of $9.33, suggesting a potential upside of 498.29%. Given Sintx Technologies’ stronger consensus rating and higher probable upside, analysts clearly believe Sintx Technologies is more favorable than Advanced Biomedical Technologies.

About Sintx Technologies

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

About Advanced Biomedical Technologies

Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures. The company was formerly known as Geostar Mineral Corporation and changed its name to Advanced Biomedical Technologies, Inc. in March 2009. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York.